Literature DB >> 32792071

Understanding decidual vasculopathy and the link to preeclampsia: A review.

D U Stevens1, J A de Nobrega Teixeira2, M E A Spaanderman3, J Bulten4, J M G van Vugt5, S Al-Nasiry2.   

Abstract

Preeclampsia is the archetype of a spectrum of clinical disorders related to abnormal placental development or function, characterized by placental histological lesions. Among those lesions, decidual vasculopathy is a term used to describe lesions of maternal spiral arteries, which are encountered on placental examination in about half of the women with preeclampsia. The morphological features of the lesions include perivascular lymphocytic infiltration, fibrinoid necrosis and foam cell incorporation within the vessel wall. Due to the resemblance of the latter characteristic to atherosclerosis, they are alternatively termed acute atherosis. Decidual vasculopathy correlates with worse maternal and neonatal outcomes, as well as placental pathology. In this article, we review the available literature on decidual vasculopathy and address the pitfalls in histological analysis of the lesions, including the varying definitions of the lesions and sample collection methods. We also discuss the current evidence on the etiology of the lesions and propose a novel hypothesis linking the three etiological pathways to the formation of decidual vasculopathy and, ultimately, the emergence of the heterogeneous group of placental dysfunction disorders, known as the great obstetric syndromes.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acute atherosis; Decidual vasculopathy; Preeclampsia; Spiral artery remodeling

Mesh:

Year:  2020        PMID: 32792071     DOI: 10.1016/j.placenta.2020.06.020

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  2 in total

1.  Low-dose aspirin therapy improves decidual arteriopathy in pregnant women with a history of preeclampsia.

Authors:  Kayo Tomimori-Gi; Shinji Katsuragi; Yuki Kodama; Naoshi Yamada; Hiroshi Sameshima; Kazunari Maekawa; Atsushi Yamashita; Toshihiro Gi; Yuichiro Sato
Journal:  Virchows Arch       Date:  2022-07-30       Impact factor: 4.535

2.  Endocan, a Soluble Marker of Endothelial Cell Activation Is a Molecular Marker of Disease Severity in Women with Preeclampsia.

Authors:  Sarah N Cross; Irina A Buhimschi; Christina Duzyj Buniak; Lydia Shook; Megan McCarthy; John Hardy; Yara El-Helou; Guomao Zhao; Catalin S Buhimschi
Journal:  Reprod Sci       Date:  2022-02-03       Impact factor: 2.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.